Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan RNA Vaccines market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan RNA Vaccines market. Detailed analysis of key players, along with key growth strategies adopted by RNA Vaccines industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Moderna Therapeutics
Tiba Biotechnology
Argos Therapeutics
Sangamo Therapeutics
CureVac
BioNTech
Ethris
In-Cell-Art
Translate Bio
eTheRNA
By Type:
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
By End-User:
Infectious Disease
Cancer
Other
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of RNA Vaccines Market
-
1.3 Market Segment by Type
1.3.1 Japan RNA Vaccines Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine from 2014 to 2026
1.3.2 Japan RNA Vaccines Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine from 2014 to 2026
1.3.3 Japan RNA Vaccines Market Size and Growth Rate of Infection Prevention MRNA Vaccine from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan RNA Vaccines Market Size and Growth Rate of Infectious Disease from 2014 to 2026
1.4.2 Japan RNA Vaccines Market Size and Growth Rate of Cancer from 2014 to 2026
1.4.3 Japan RNA Vaccines Market Size and Growth Rate of Other from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido RNA Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku RNA Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto RNA Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu RNA Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki RNA Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku RNA Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku RNA Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu RNA Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of RNA Vaccines Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of RNA Vaccines by Major Types
3.4.1 Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine
3.4.2 Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine
3.4.3 Market Size and Growth Rate of Infection Prevention MRNA Vaccine
4 Segmentation of RNA Vaccines Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of RNA Vaccines by Major End-Users
4.4.1 Market Size and Growth Rate of RNA Vaccines in Infectious Disease
4.4.2 Market Size and Growth Rate of RNA Vaccines in Cancer
4.4.3 Market Size and Growth Rate of RNA Vaccines in Other
5 Market Analysis by Regions
-
5.1 Japan RNA Vaccines Production Analysis by Regions
-
5.2 Japan RNA Vaccines Consumption Analysis by Regions
6 Hokkaido RNA Vaccines Landscape Analysis
-
6.1 Hokkaido RNA Vaccines Landscape Analysis by Major Types
-
6.2 Hokkaido RNA Vaccines Landscape Analysis by Major End-Users
7 Tohoku RNA Vaccines Landscape Analysis
-
7.1 Tohoku RNA Vaccines Landscape Analysis by Major Types
-
7.2 Tohoku RNA Vaccines Landscape Analysis by Major End-Users
8 Kanto RNA Vaccines Landscape Analysis
-
8.1 Kanto RNA Vaccines Landscape Analysis by Major Types
-
8.2 Kanto RNA Vaccines Landscape Analysis by Major End-Users
9 Chubu RNA Vaccines Landscape Analysis
-
9.1 Chubu RNA Vaccines Landscape Analysis by Major Types
-
9.2 Chubu RNA Vaccines Landscape Analysis by Major End-Users
10 Kinki RNA Vaccines Landscape Analysis
-
10.1 Kinki RNA Vaccines Landscape Analysis by Major Types
-
10.2 Kinki RNA Vaccines Landscape Analysis by Major End-Users
11 Chugoku RNA Vaccines Landscape Analysis
-
11.1 Chugoku RNA Vaccines Landscape Analysis by Major Types
-
11.2 Chugoku RNA Vaccines Landscape Analysis by Major End-Users
12 Shikoku RNA Vaccines Landscape Analysis
-
12.1 Shikoku RNA Vaccines Landscape Analysis by Major Types
-
12.2 Shikoku RNA Vaccines Landscape Analysis by Major End-Users
13 Kyushu RNA Vaccines Landscape Analysis
-
13.1 Kyushu RNA Vaccines Landscape Analysis by Major Types
-
13.2 Kyushu RNA Vaccines Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Moderna Therapeutics
14.1.1 Moderna Therapeutics Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Tiba Biotechnology
14.2.1 Tiba Biotechnology Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Argos Therapeutics
14.3.1 Argos Therapeutics Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Sangamo Therapeutics
14.4.1 Sangamo Therapeutics Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 CureVac
14.5.1 CureVac Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 BioNTech
14.6.1 BioNTech Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Ethris
14.7.1 Ethris Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 In-Cell-Art
14.8.1 In-Cell-Art Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Translate Bio
14.9.1 Translate Bio Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 eTheRNA
14.10.1 eTheRNA Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
The List of Tables and Figures (Totals 85 Figures and 159 Tables)
Figure Japan RNA Vaccines Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine from 2014 to 2026
Figure Japan RNA Vaccines Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine from 2014 to 2026
Figure Japan RNA Vaccines Market Size and Growth Rate of Infection Prevention MRNA Vaccine from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan RNA Vaccines Market Size and Growth Rate of Infectious Disease from 2014 to 2026
Figure Japan RNA Vaccines Market Size and Growth Rate of Cancer from 2014 to 2026
Figure Japan RNA Vaccines Market Size and Growth Rate of Other from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido RNA Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku RNA Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto RNA Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu RNA Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki RNA Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku RNA Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku RNA Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu RNA Vaccines Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of RNA Vaccines Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of RNA Vaccines
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of RNA Vaccines by Different Types from 2014 to 2026
-
Table Consumption Share of RNA Vaccines by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Individualized Cancer Treatment MRNA Vaccine
Figure Market Size and Growth Rate of Infectious Disease Treatment MRNA Vaccine
Figure Market Size and Growth Rate of Infection Prevention MRNA Vaccine
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of RNA Vaccines by Different End-Users from 2014 to 2026
-
Table Consumption Share of RNA Vaccines by Different End-Users from 2014 to 2026
Figure Japan RNA Vaccines Market Size and Growth Rate of Infectious Disease from 2014 to 2026
Figure Japan RNA Vaccines Market Size and Growth Rate of Cancer from 2014 to 2026
Figure Japan RNA Vaccines Market Size and Growth Rate of Other from 2014 to 2026
-
Table Japan RNA Vaccines Production by Regions
-
Table Japan RNA Vaccines Production Share by Regions
-
Figure Japan RNA Vaccines Production Share by Regions in 2014
-
Figure Japan RNA Vaccines Production Share by Regions in 2018
-
Figure Japan RNA Vaccines Production Share by Regions in 2026
-
Table Japan RNA Vaccines Consumption by Regions
-
Table Japan RNA Vaccines Consumption Share by Regions
-
Figure Japan RNA Vaccines Consumption Share by Regions in 2014
-
Figure Japan RNA Vaccines Consumption Share by Regions in 2018
-
Figure Japan RNA Vaccines Consumption Share by Regions in 2026
-
Table Hokkaido RNA Vaccines Consumption by Types from 2014 to 2026
-
Table Hokkaido RNA Vaccines Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido RNA Vaccines Consumption Share by Types in 2014
-
Figure Hokkaido RNA Vaccines Consumption Share by Types in 2018
-
Figure Hokkaido RNA Vaccines Consumption Share by Types in 2026
-
Table Hokkaido RNA Vaccines Consumption by End-Users from 2014 to 2026
-
Table Hokkaido RNA Vaccines Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido RNA Vaccines Consumption Share by End-Users in 2014
-
Figure Hokkaido RNA Vaccines Consumption Share by End-Users in 2018
-
Figure Hokkaido RNA Vaccines Consumption Share by End-Users in 2026
-
Table Tohoku RNA Vaccines Consumption by Types from 2014 to 2026
-
Table Tohoku RNA Vaccines Consumption Share by Types from 2014 to 2026
-
Figure Tohoku RNA Vaccines Consumption Share by Types in 2014
-
Figure Tohoku RNA Vaccines Consumption Share by Types in 2018
-
Figure Tohoku RNA Vaccines Consumption Share by Types in 2026
-
Table Tohoku RNA Vaccines Consumption by End-Users from 2014 to 2026
-
Table Tohoku RNA Vaccines Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku RNA Vaccines Consumption Share by End-Users in 2014
-
Figure Tohoku RNA Vaccines Consumption Share by End-Users in 2018
-
Figure Tohoku RNA Vaccines Consumption Share by End-Users in 2026
-
Table Kanto RNA Vaccines Consumption by Types from 2014 to 2026
-
Table Kanto RNA Vaccines Consumption Share by Types from 2014 to 2026
-
Figure Kanto RNA Vaccines Consumption Share by Types in 2014
-
Figure Kanto RNA Vaccines Consumption Share by Types in 2018
-
Figure Kanto RNA Vaccines Consumption Share by Types in 2026
-
Table Kanto RNA Vaccines Consumption by End-Users from 2014 to 2026
-
Table Kanto RNA Vaccines Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto RNA Vaccines Consumption Share by End-Users in 2014
-
Figure Kanto RNA Vaccines Consumption Share by End-Users in 2018
-
Figure Kanto RNA Vaccines Consumption Share by End-Users in 2026
-
Table Chubu RNA Vaccines Consumption by Types from 2014 to 2026
-
Table Chubu RNA Vaccines Consumption Share by Types from 2014 to 2026
-
Figure Chubu RNA Vaccines Consumption Share by Types in 2014
-
Figure Chubu RNA Vaccines Consumption Share by Types in 2018
-
Figure Chubu RNA Vaccines Consumption Share by Types in 2026
-
Table Chubu RNA Vaccines Consumption by End-Users from 2014 to 2026
-
Table Chubu RNA Vaccines Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu RNA Vaccines Consumption Share by End-Users in 2014
-
Figure Chubu RNA Vaccines Consumption Share by End-Users in 2018
-
Figure Chubu RNA Vaccines Consumption Share by End-Users in 2026
-
Table Kinki RNA Vaccines Consumption by Types from 2014 to 2026
-
Table Kinki RNA Vaccines Consumption Share by Types from 2014 to 2026
-
Figure Kinki RNA Vaccines Consumption Share by Types in 2014
-
Figure Kinki RNA Vaccines Consumption Share by Types in 2018
-
Figure Kinki RNA Vaccines Consumption Share by Types in 2026
-
Table Kinki RNA Vaccines Consumption by End-Users from 2014 to 2026
-
Table Kinki RNA Vaccines Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki RNA Vaccines Consumption Share by End-Users in 2014
-
Figure Kinki RNA Vaccines Consumption Share by End-Users in 2018
-
Figure Kinki RNA Vaccines Consumption Share by End-Users in 2026
-
Table Chugoku RNA Vaccines Consumption by Types from 2014 to 2026
-
Table Chugoku RNA Vaccines Consumption Share by Types from 2014 to 2026
-
Figure Chugoku RNA Vaccines Consumption Share by Types in 2014
-
Figure Chugoku RNA Vaccines Consumption Share by Types in 2018
-
Figure Chugoku RNA Vaccines Consumption Share by Types in 2026
-
Table Chugoku RNA Vaccines Consumption by End-Users from 2014 to 2026
-
Table Chugoku RNA Vaccines Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku RNA Vaccines Consumption Share by End-Users in 2014
-
Figure Chugoku RNA Vaccines Consumption Share by End-Users in 2018
-
Figure Chugoku RNA Vaccines Consumption Share by End-Users in 2026
-
Table Shikoku RNA Vaccines Consumption by Types from 2014 to 2026
-
Table Shikoku RNA Vaccines Consumption Share by Types from 2014 to 2026
-
Figure Shikoku RNA Vaccines Consumption Share by Types in 2014
-
Figure Shikoku RNA Vaccines Consumption Share by Types in 2018
-
Figure Shikoku RNA Vaccines Consumption Share by Types in 2026
-
Table Shikoku RNA Vaccines Consumption by End-Users from 2014 to 2026
-
Table Shikoku RNA Vaccines Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku RNA Vaccines Consumption Share by End-Users in 2014
-
Figure Shikoku RNA Vaccines Consumption Share by End-Users in 2018
-
Figure Shikoku RNA Vaccines Consumption Share by End-Users in 2026
-
Table Kyushu RNA Vaccines Consumption by Types from 2014 to 2026
-
Table Kyushu RNA Vaccines Consumption Share by Types from 2014 to 2026
-
Figure Kyushu RNA Vaccines Consumption Share by Types in 2014
-
Figure Kyushu RNA Vaccines Consumption Share by Types in 2018
-
Figure Kyushu RNA Vaccines Consumption Share by Types in 2026
-
Table Kyushu RNA Vaccines Consumption by End-Users from 2014 to 2026
-
Table Kyushu RNA Vaccines Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu RNA Vaccines Consumption Share by End-Users in 2014
-
Figure Kyushu RNA Vaccines Consumption Share by End-Users in 2018
-
Figure Kyushu RNA Vaccines Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Moderna Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Moderna Therapeutics
Figure Sales and Growth Rate Analysis of Moderna Therapeutics
Figure Revenue and Market Share Analysis of Moderna Therapeutics
Table Product and Service Introduction of Moderna Therapeutics
Table Company Profile and Development Status of Tiba Biotechnology
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tiba Biotechnology
Figure Sales and Growth Rate Analysis of Tiba Biotechnology
Figure Revenue and Market Share Analysis of Tiba Biotechnology
Table Product and Service Introduction of Tiba Biotechnology
Table Company Profile and Development Status of Argos Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Argos Therapeutics
Figure Sales and Growth Rate Analysis of Argos Therapeutics
Figure Revenue and Market Share Analysis of Argos Therapeutics
Table Product and Service Introduction of Argos Therapeutics
Table Company Profile and Development Status of Sangamo Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sangamo Therapeutics
Figure Sales and Growth Rate Analysis of Sangamo Therapeutics
Figure Revenue and Market Share Analysis of Sangamo Therapeutics
Table Product and Service Introduction of Sangamo Therapeutics
Table Company Profile and Development Status of CureVac
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CureVac
Figure Sales and Growth Rate Analysis of CureVac
Figure Revenue and Market Share Analysis of CureVac
Table Product and Service Introduction of CureVac
Table Company Profile and Development Status of BioNTech
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioNTech
Figure Sales and Growth Rate Analysis of BioNTech
Figure Revenue and Market Share Analysis of BioNTech
Table Product and Service Introduction of BioNTech
Table Company Profile and Development Status of Ethris
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ethris
Figure Sales and Growth Rate Analysis of Ethris
Figure Revenue and Market Share Analysis of Ethris
Table Product and Service Introduction of Ethris
Table Company Profile and Development Status of In-Cell-Art
Table Sales, Revenue, Sales Price and Gross Margin Analysis of In-Cell-Art
Figure Sales and Growth Rate Analysis of In-Cell-Art
Figure Revenue and Market Share Analysis of In-Cell-Art
Table Product and Service Introduction of In-Cell-Art
Table Company Profile and Development Status of Translate Bio
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Translate Bio
Figure Sales and Growth Rate Analysis of Translate Bio
Figure Revenue and Market Share Analysis of Translate Bio
Table Product and Service Introduction of Translate Bio
Table Company Profile and Development Status of eTheRNA
Table Sales, Revenue, Sales Price and Gross Margin Analysis of eTheRNA
Figure Sales and Growth Rate Analysis of eTheRNA
Figure Revenue and Market Share Analysis of eTheRNA
Table Product and Service Introduction of eTheRNA
-
